Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluorouracil via Colon for Colorectal Cancer
NCT06385418Phase 2Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- May 2024
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in colorectal cancer (CRC), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Objective Response Rate at 6 months. Started May 2024; status: recruiting.
02
Drugs
fluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06385418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06385418.